{"id":252690,"date":"2012-08-15T05:13:08","date_gmt":"2012-08-15T05:13:08","guid":{"rendered":"http:\/\/www.eugenesis.com\/aidp-announces-it-has-been-granted-u-s-patents-for-magtein%e2%84%a2\/"},"modified":"2012-08-15T05:13:08","modified_gmt":"2012-08-15T05:13:08","slug":"aidp-announces-it-has-been-granted-u-s-patents-for-magtein","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/anti-aging-medicine\/aidp-announces-it-has-been-granted-u-s-patents-for-magtein.php","title":{"rendered":"AIDP announces it has been granted U.S. patents for Magtein\u2122"},"content":{"rendered":"<p><p>    CITY OF INDUSTRY, Calif., Aug. 14, 2012 \/PRNewswire\/ -- AIDP,    Inc., the distributors of Magtein magnesium L-threonate,    expected to be the next breakthrough ingredient for cognitive    health, has been awarded two patents for magnesium compositions    and uses for cognitive function (Patent 8,178,118) and    neurological disorders (Patent 8,142,803).  <\/p>\n<p>    (Logo: <a href=\"http:\/\/photos.prnewswire.com\/prnh\/20120814\/SF56977LOGO\" rel=\"nofollow\">http:\/\/photos.prnewswire.com\/prnh\/20120814\/SF56977LOGO<\/a>)  <\/p>\n<p>    The patents, titled \"Magnesium compositions and uses thereof    for cognitive function\" (Patent 8,178,118) and \"Magnesium    compositions and uses thereof for neurological disorders\"    (Patent 8,142,803) are among the four U.S. patents awarded from    seven ongoing patent applications, including international    rights. These patents protect Magtein's unique magnesium    compositions and its use for any magnesium    L-threonate-containing food, nutritional supplements and drugs    for enhancing cognitive function or ameliorating the effects of    a neurological disorder. The use of these products is    applicable for improving the health of people suffering from    loss of cognitive function, loss of memory, Alzheimer's    disease, depression, attention deficit hyperactivity disorder,    Amyotrophic lateral sclerosis (ALS), Parkinson's disease,    migraine, anxiety disorder, and mood disorder, as some    representative of cognitive and neurological disorders.  <\/p>\n<p>    \"We truly believe that Magtein is a game changing ingredient    that will benefit millions of busy and stressed consumers by    helping to improve their quality of life,\" says Edward Lee    Ph.D., AIDP president.  <\/p>\n<p>    \"AIDP, as the exclusive provider of all Magtein magnesium    L-threonate, is uniquely positioned to serve the functional    food and beverage marketplace to support the cognitive health    category,\" added Dr. Lee.  <\/p>\n<p>    Discovered byGuosong Liu, M.D., Ph.D., and a group of    scientists at Massachusetts Institute of Technology (MIT), and    Tsinghua University in Beijing, China, studies on Magtein have    been published in prestigious journals of neuroscience     Neuron (January 2010) and The Journal of    Neuroscience (October 2011). With cognitive diseases the    seventh leading cause of death in the U.S. and growing at an    alarming rate, Magtein, which has self-affirmed GRAS status, is    the only form of magnesium proven to significantly increase    brain magnesium levels. Furthermore, animal research showed    Magtein improved short-term and long-term memory as well as    spatial recognition.  <\/p>\n<p>    Dr. Liu is the president and founder of the Center for Learning    and Memory, School of Medicine, Tsinghua University, Beijing,    China and Adjunct Full Professor of the Center for Learning and    Memory, University of Texas Austin. Dr. Liu is an investigator    at the Picower Institute for Learning and Memory and is a    former professor at the department of brain and cognitive    science and the department of biology at MIT.  <\/p>\n<p>    For over 15 years, AIDP, Inc. based in City of Industry, CA,    has been a leader in functional ingredients for a wide-range of    applications from vitamins, minerals and amino acids, to    specialty and proprietary products. Pioneering breakthroughs    for the research and development of proprietary ingredients for    bone, joint and cognitive health under the anti-aging platform,    the AIDP mission is to achieve ultimate customer satisfaction    through creative product innovation and superior service.  <\/p>\n<p>    For more information about Magtein magnesium L-threonate    studies, call Kathy Lund, AIDP vice president of business    development and marketing, at 303.734.0860 or visit <a href=\"http:\/\/www.AIDP.com\" rel=\"nofollow\">http:\/\/www.AIDP.com<\/a>.  <\/p>\n<\/p>\n<p>Follow this link:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/aidp-announces-granted-u-patents-140000974.html;_ylt=A2KJNF_cLytQ_0AAmOL_wgt.\" title=\"AIDP announces it has been granted U.S. patents for Magtein\u2122\">AIDP announces it has been granted U.S. patents for Magtein\u2122<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> CITY OF INDUSTRY, Calif., Aug. 14, 2012 \/PRNewswire\/ -- AIDP, Inc., the distributors of Magtein magnesium L-threonate, expected to be the next breakthrough ingredient for cognitive health, has been awarded two patents for magnesium compositions and uses for cognitive function (Patent 8,178,118) and neurological disorders (Patent 8,142,803).  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/anti-aging-medicine\/aidp-announces-it-has-been-granted-u-s-patents-for-magtein.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577503],"tags":[],"class_list":["post-252690","post","type-post","status-publish","format-standard","hentry","category-anti-aging-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/252690"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=252690"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/252690\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=252690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=252690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=252690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}